Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,841
Sort by:
2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 22,050.00
... new report from VPGMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
410 pages
2017 Latin America Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 15,750.00
... new report from VPGMarketResearch.com provides granular analysis of the Latin America diagnostic testing market, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
260 pages
Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)
US$ 1,250.00
... the growth of cervical cancer test market in the developing countries. Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia) report published by Renub Research provides a comprehensive analysis of this market and future ...
January 2017
121 pages
2017 New Zealand Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments of major ...
January 2017
535 pages
2017 United Arab Emirates Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... others. Instrumentation Review Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling ... . Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments ...
January 2017
535 pages
2017 Argentina Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Bahrain Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Kuwait Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Qatar Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
Global Cancer Diagnostics Market Research Report 2017
US$ 2,850.00
Cancer Diagnostics Report by Material, Application, and Geography тАУ Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market ... Cancer Diagnostics Market; 3) the North American Cancer Diagnostics Market; 4) the European Cancer Diagnostics Market; 5) market ...
January 2017
156 pages
2017 Argentina Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Argentina diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
